CLINICAL_TRIALS
trial_result
· 2025-02-03
Clinical Trial Update: rTMS for MDD: 5.5cm Rule vs. F3 Targeting [NA]
Summary
Completed study comparing 5.5 cm rule versus F3 targeting for repetitive transcranial magnetic stimulation (rTMS) in major depressive disorder, with results pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nicholas Trapp | Conditions: Major Depressive Disorder, Depression | NA | Status: COMPLETED | Results posted: 2025-02-03